Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences
SafetyAlerts
November 12,  2003

Bristol-Myers Squibb Has Recalled Estrace tablets

(SafetyAlerts) - The FDA has released the following information.

PRODUCT
a) Estrace tablets (estradiol tablets, USP) 0.5mg,
physician samples, 7 and 21 count boxes, Rx Only, NOT AN
ORAL CONTRACEPTIVE. Recall # D-037-4;
b) Estrace tablets (estradiol tablets, USP) 1mg, physician
sample, 7 and 21 count boxes, Rx Only. NOT AN ORAL
CONTRACEPTIVE! Recall # D-038-4;
c) Estrace tablets (estradiol tablets, USP) 2mg, physician
sample, 7 and 21 count boxes, Rx Only. NOT AN ORAL
CONTRACEPTIVE! Recall # D-039-4.

CODE
a), b), and c) 64-GCA07.

RECALLING FIRM/MANUFACTURER
Bristol-Myers Squibb Company, Princeton, N.J., by letter on August 18, 2003. Firm initiated recall is ongoing.

REASON
Dissolution failure.

VOLUME OF PRODUCT IN COMMERCE
106,871 blisters.

DISTRIBUTION
Nationwide
.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.